Clinuvel Release: Successful Drug Trial Results for Light Intolerant ‘Shadow Jumpers’

MELBOURNE, Australia--(BUSINESS WIRE)--A new Australian drug has been shown to assist in protecting patients with a rare genetic disorder that makes their skin toxic to light and UV, and previously forced them to live in the shadows.